Novartis AG

Business Description

Novartis AG is a Swiss-based global pharmaceutical company founded in 1996 and headquartered in Basel, with operations spanning research, manufacturing, and sales across international markets. The company develops and sells a broad range of medicines targeting serious conditions including heart failure, cancer, autoimmune diseases, and rare genetic disorders. Its portfolio includes well-established treatments such as Entresto for heart failure, Cosentyx for inflammatory conditions, Kisqali for certain cancers, and Zolgensma for spinal muscular atrophy, among many others. Novartis also holds a collaboration agreement with Alnylam Pharmaceuticals to develop and commercialize Leqvio, a therapy designed to lower harmful cholesterol levels.